Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 3/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FURIN | P09958 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29867871 | 0.90 | ALDH1A1 (0.47) | ALDH1A1OPRM1OPRD1MAPTLAP3 | |
| SCHEMBL29989920 | 0.87 | OPRD1 (0.48) | ALDH1A1OPRM1OPRD1MAPTLAP3 | |
| SCHEMBL11566796 | 0.87 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL11567697 | 0.87 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL11567184 | 0.87 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL11566787 | 0.87 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL11567194 | 0.87 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29614776 | 0.86 | CTSD (0.53) | CTSBOPRM1OPRD1 | |
| SCHEMBL30051918 | 0.83 | ALDH1A1 (0.49) | CTSBALDH1A1OPRM1OPRD1MAPT | |
| SCHEMBL14842719 | 0.81 | ALDH1A1 (0.56) | ALDH1A1MAPTLAP3MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240390482-A1 | HIV-1 ENVELOPE GLYCOPEPTIDE NANOPARTICLES AND THEIR USES | UNIV DUKE (US) | 2024-11-28 | — | — | US | disclosed |
| US-20240316170-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Limited (GB) | 2024-09-26 | — | — | US | disclosed |
| EP-4305057-A1 | HIV-1 ENVELOPE GLYCOPEPTIDE NANOPARTICLES AND THEIR USES | Duke University (US) | 2024-01-17 | — | — | EP | disclosed |
| EP-4236994-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Ltd. (GB) | 2023-09-06 | — | — | EP | disclosed |
| WO-2022192262-A1 | HIV-1 ENVELOPE GLYCOPEPTIDE NANOPARTICLES AND THEIR USES | DUKE UNIVERSITY (US) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022090679-A1 | CORONAVIRUS POLYPEPTIDE | Oxford Vacmedix UK Limited (GB) | 2022-05-05 | — | — | WO | disclosed |
| WO-2022090716-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Limited (GB) | 2022-05-05 | — | — | WO | disclosed |